2'-FL Dietary Supplement Trial for IBD
Phase 1/2
116
about 7.8 years
11–25
3 sites in CT, OH
What this study is about
This trial is testing a dietary supplement called 2'-FL in people with Inflammatory Bowel Diseases (IBD), Crohn's Disease, and Ulcerative Colitis. Participants will receive either 2'-FL or a placebo daily while on stable anti-TNF therapy. The goal is to see if 2'-FL is safe and well-tolerated, and whether it affects the gut microbiome.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Placebo
- 2.Take 2'-Fucosyllactose
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Mean Gastrointestinal Symptom Rating Scale (GSRS) in participants who receive 2'-fucosyllactose (2'FL) or dextrose placebo
Gastroenterology